Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 1
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Effective early diagnosis for NSCLC: an algorithm.
Zarogoulidis P, Matthaios D, Kosmidis C, Hohenforst-Schmidt W, Tsakiridis K, Mpaka S, Boukovinas I, Drougas D, Theofilatou V, Zaric B, Courcoutsakis N, Nikolaidis G, Huang H, Bai C. Zarogoulidis P, et al. Among authors: drougas d. Expert Rev Respir Med. 2021 Nov;15(11):1437-1445. doi: 10.1080/17476348.2021.1969916. Epub 2021 Aug 23. Expert Rev Respir Med. 2021. PMID: 34403620
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G.
Zarogoulidis P, Hohenforst-Schmidt W, Huang H, Zhou J, Wang Q, Wang X, Xia Y, Ding Y, Bai C, Kosmidis C, Sapalidis K, Sardeli C, Tsakiridis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Baka S, Athanasiou E, Hatzibougias D, Michalopoulou-Manoloutsiou E, Petanidis S, Drougas D, Drevelegas K, Paliouras D, Barbetakis N, Vagionas A, Freitag L, Lallas A, Boukovinas I, Petridis D, Ioannidis A, Matthaios D, Romanidis K, Karapantzou C. Zarogoulidis P, et al. Among authors: drougas d. J Cancer. 2021 Mar 5;12(9):2560-2569. doi: 10.7150/jca.55322. eCollection 2021. J Cancer. 2021. PMID: 33854617 Free PMC article.
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.
Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, Vagionas A, Hohenforst-Schmidt W, Freitag L, Huang H, Bai C, Drougas D, Theofilatou V, Romanidis K, Perdikouri EI, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Perin B, Courcoutsakis N, Athanasiou E, Hatzibougias D, Drevelegas K, Boukovinas I, Kosmidou M, Kosmidis C. Zarogoulidis P, et al. Among authors: drougas d. J Cancer. 2020 Sep 14;11(21):6454-6459. doi: 10.7150/jca.48691. eCollection 2020. J Cancer. 2020. PMID: 33033529 Free PMC article.
Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study.
Zarogoulidis P, Petridis D, Huang H, Bai C, Hohenforst-Schmidt W, Freitag L, Baka S, Drougas D, Vagionas A, Tsakiridis K, Turner JF, Hatzibougias D, Boukovinas I, Zaric B, Kovacevic T, Ioannidis A, Courcoutsakis N, Matthaios D, Sardeli C. Zarogoulidis P, et al. Among authors: drougas d. Expert Rev Respir Med. 2021 Nov;15(11):1483-1491. doi: 10.1080/17476348.2021.1987888. Epub 2021 Oct 12. Expert Rev Respir Med. 2021. PMID: 34591723
Psoriatic arthritis due to nivolumab administration a case report and review of the literature.
Sapalidis K, Kosmidis C, Michalopoulos N, Koulouris C, Mantalobas S, Giannakidis D, Munteanu A, Surlin V, Laskou S, Zarogoulidis P, Drougas D, Sardeli C, Karapantzou C, Karapantzos I, Hohenforst-Schmidt W, Huang H, Kesisoglou I. Sapalidis K, et al. Among authors: drougas d. Respir Med Case Rep. 2018 Mar 2;23:182-187. doi: 10.1016/j.rmcr.2018.03.001. eCollection 2018. Respir Med Case Rep. 2018. PMID: 29719813 Free PMC article.
Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.
Zarogoulidis P, Athanasiou E, Tsiouda T, Hatzibougias D, Huang H, Bai C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Barbetakis N, Paliouras D, Rapti A, Drougas D, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: drougas d. Respir Med Case Rep. 2017 Aug 29;22:197-202. doi: 10.1016/j.rmcr.2017.08.017. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28879076 Free PMC article.
Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.
Zarogoulidis P, Huang H, Tsiouda T, Sardeli C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Rapti A, Papaemmanouil L, Hatzibougias D, Drougas D, Bai C, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: drougas d. Respir Med Case Rep. 2017 Oct 26;22:283-286. doi: 10.1016/j.rmcr.2017.10.006. eCollection 2017. Respir Med Case Rep. 2017. PMID: 29124007 Free PMC article.